What is the recommended treatment for hand, foot, and mouth disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Hand, Foot, and Mouth Disease

Hand, foot, and mouth disease treatment is primarily supportive, focusing on pain relief and hydration, as the disease is self-limiting and resolves in 7-10 days without specific antiviral therapy in most cases 1, 2.

Mild Cases (Majority of Patients)

Most cases can be managed as outpatients with symptomatic treatment only 3. The treatment approach includes:

Pain Management

  • Acetaminophen or ibuprofen for fever and pain control 2
  • Oral lidocaine is NOT recommended 2
  • For oral pain, focus on maintaining hydration despite discomfort

Hydration

  • Ensure adequate fluid intake, as painful oral ulcerations may reduce oral intake
  • This is the primary concern in mild cases

Isolation

  • Isolate patients to prevent cross-infection 3
  • Best prevention methods are handwashing and disinfecting contaminated surfaces 2

Severe/Complicated Cases

For severe cases with neurologic or cardiopulmonary complications, consider intravenous immunoglobulin (IVIG) 1. The Chinese guidelines 3 recommend IVIG for severe cases, though this differs from WHO/US-CDC recommendations.

Warning Signs Requiring Escalation of Care

Watch for these indicators of deterioration 3:

  • Persistent high fever
  • Nervous system involvement
  • Worsening respiratory rate/rhythm
  • Circulatory dysfunction
  • Elevated peripheral WBC count
  • Elevated blood glucose
  • Elevated blood lactate

Critical Recognition Points

Pay particular attention to 3:

  • Children under 3 years old
  • EV-A71 infections (more severe than coxsackievirus A16)
  • Disease duration less than 3 days
  • These patients require close monitoring for progression to severe disease

Antiviral Therapy

Currently, no specific antiviral agents are approved for HFMD treatment 1, 2. However:

  • One case report showed dramatic improvement with valacyclovir in an adult patient (resolution within 48 hours) 4, though this is off-label use requiring further validation
  • Drugs under investigation include ribavirin, suramin, mulberroside C, and sertraline 1

Traditional Chinese Medicine

The Chinese guidelines differ from Western recommendations by including traditional Chinese herbs (TCH). Lan-Qin showed higher recovery rates in mild cases in one retrospective study 5, though this requires validation in randomized trials.

Common Pitfalls to Avoid

  1. Do not use oral lidocaine - it is not recommended despite oral pain 2
  2. Do not prescribe antibiotics - HFMD is viral; antibiotics have no role unless secondary bacterial infection occurs
  3. Do not dismiss cases in adults - while 95% occur in children under 5, adults can be affected 6
  4. Do not miss the narrow window for intervention in severe cases - stages 2 and 3 are critical for preventing progression to stage 4 (cardiopulmonary failure) 3

Key Complications to Monitor

The main causes of death are 1:

  • Circulatory failure from myocardial impairment
  • Neurogenic pulmonary edema from brainstem damage

Fortunately, 99.8% of cases recover 5, and the disease typically resolves in 7-10 days without sequelae 1, 2.

Prevention

Vaccination with inactivated EV-A71 vaccines (available in China) shows over 90% efficacy in preventing severe HFMD 7. Other preventive measures include hand hygiene, breastfeeding, and environmental sanitation 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.